[Evaluation of amyxin effect in prophylaxis of acute respiratory viral infections].

Abstract

The results of the evaluation of the oral inductor of endogenic interferon (amyxin), manufactured in Russia are presented. The use of amyxin was found to produce a drop in morbidity in acute respiratory virus infections (ARVI) among medical workers 3.4 times, i.e. the preparation exhibited a pronounced prophylactic effect with respect to ARVI. The use of the preparation was accompanied by a decrease in the number of manifest forms of ARVI. Persons given the preparation often had ARVI in a mild or asymptomatic form.

• Authors: E P Sel'kova, V N Iakovlev, T A Semenenko, N N Filatov, T P Gotvianskaia, G A Danilina, T N Pantiukhova, G Iu Nikitina, M Kh Tur'ianov
• Journal: Zhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol) 2001 May-Jun Issue 3 Pg. 42-6 ISSN: 0372-9311 [Print] Russia (Federation)
• Vernacular Title: Otsenka profilakticheskogo éffekta amiksina v otnoshenii ostrykh respiratornykh virusnykh infektsiĭ.
• PMID: 11550558 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Interferon Inducers
• Tilorone

Topics

• Acute Disease
• Humans
• Interferon Inducers (therapeutic use)
• Moscow (epidemiology)
• Respiratory Tract Infections (epidemiology, prevention & control)
• Tilorone (therapeutic use)
• Virus Diseases (epidemiology, prevention & control)